The aggregate amount of acquired in-process research and development recognized as part of a business combination.

No definition available.

Name:	mack_AcquiredInProcessResearchAndDevelopment
Namespace Prefix:	mack_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Date when the business acquisition agreement was executed, in CCYY-MM-DD format.

+ References

No definition available.

+ Details

Name:	us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1
Namespace Prefix:	us-gaap_
Data Type:	xbrli:dateItemType
Balance Type:	na
Period Type:	duration

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_BusinessAcquisitionLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.

+ References

No definition available.

+ Details

Name:	us-gaap_FiniteLivedIntangibleAssetUsefulLife
Namespace Prefix:	us-gaap_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Remaining amortization period of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.

+ References

No definition available.

+ Details

Name:	us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
Namespace Prefix:	us-gaap_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Amount of increase in assets, excluding financial assets, lacking physical substance with a definite life, resulting from a business combination.

+ References

No definition available.

+ Details

Name:	us-gaap_FinitelivedIntangibleAssetsAcquired1
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 3
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16373-109275

+ Details

Name:	us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Details

Name:	us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=mack_CoreNanoCarrierTechnologyMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis=mack_OtherInprocessResearchAndDevelopmentProgramMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_BusinessAcquisitionAxis=mack_HermesBioSciencesIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis=mack_AntibodyTargetedNanotherapeuticProgramWithChemotherapyDrugMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis=mack_NanotherapeuticProgramWithChemotherapyDrugMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Goodwill and Intangible Assets, Net - Additional Information (Detail) - USD ($) $ in Millions	3 Months Ended	12 Months Ended
	Sep. 30, 2013	Dec. 31, 2015
Business Acquisition [Line Items]
Weighted-average remaining amortization period of intangible assets		10 years 7 months 6 days
Core Nano Carrier Technology [Member]
Business Acquisition [Line Items]
Amortization period of intangible assets		10 years
Other In-process Research and Development Program [Member]
Business Acquisition [Line Items]
Impairment charge	$ 0.8
Hermes BioSciences, Inc. [Member]
Business Acquisition [Line Items]
Acquired IPR&D recognized in a business combination		$ 7.0
Acquisition date		Oct. 06, 2009
Hermes BioSciences, Inc. [Member] \| Core Nano Carrier Technology [Member]
Business Acquisition [Line Items]
Acquired intangible assets		$ 3.2
Hermes BioSciences, Inc. [Member] \| Antibody Targeted Nanotherapeutic Program with Chemotherapy Drug [Member]
Business Acquisition [Line Items]
Acquired IPR&D recognized in a business combination		2.8
Hermes BioSciences, Inc. [Member] \| Nanotherapeutic Program with Chemotherapy Drug [Member]
Business Acquisition [Line Items]
Acquired IPR&D recognized in a business combination		3.4
Hermes BioSciences, Inc. [Member] \| Other In-process Research and Development Program [Member]
Business Acquisition [Line Items]
Acquired IPR&D recognized in a business combination		$ 0.8